In a significant case before the U.S. Supreme Court, oral arguments have been heard regarding the FDA’s approval and deregulation of the abortion pill mifepristone. The Alliance for Hippocratic Medicine (AHM), representing pro-life medical groups, has challenged the FDA’s decision, particularly regarding prescribing the drug without an in-person doctor’s visit and allowing mail distribution. Justices expressed concerns over safety issues but questioned whether AHM had the legal standing to sue. The outcome of this case, expected in June, could have far-reaching implications.
Supreme Court Questions FDA on Mifepristone Safety in Landmark Abortion Case, US
Date:
Updated: [falahcoin_post_modified_date]
More like thisRelated
Revolutionary Small Business Exchange Network Connects Sellers and Buyers
Revolutionary SBEN connects small business sellers and buyers, transforming the way businesses are bought and sold in the U.S.
District 1 Commissioner Race Results Delayed by Recounts & Ballot Reviews, US
District 1 Commissioner Race in Orange County faces delays with recounts and ballot reviews. Find out who will come out on top in this close election.
Fed Minutes Hint at Potential Rate Cut in September amid Economic Uncertainty, US
Federal Reserve minutes suggest potential rate cut in September amid economic uncertainty. Find out more about the upcoming policy decisions.
Baltimore Orioles Host First-Ever ‘Faith Night’ with Players Sharing Testimonies, US
Experience the powerful testimonies of Baltimore Orioles players on their first-ever 'Faith Night.' Hear how their faith impacts their lives on and off the field.
